BG

Vericel

NASDAQ · VCEL·Cambridge, MA·Small-cap·Approved

Commercial-stage specialty biologics company focused on advanced therapies for sports medicine and severe burn care. MACI is the only FDA-approved autologous cell therapy for cartilage repair in the knee; Epicel is a permanent skin replacement for adult and pediatric severe burns; NexoBrid is an enzymatic eschar removal product for severe thermal burns.

Decks (1)

TitleOccasionDateSlidesSource
Vericel Corporate Presentation — March 2026Corporate overviewMarch 15, 202623PDF